EEG Abnormalities Are Associated with Poorer Depressive Symptom Outcomes with Escitalopram and Venlafaxine-XR, but Not Sertraline

Clinical EEG and Neuroscience

Volumn 48, Issue 1, 2017, Pages 33-40

  Arns, Martijn ^a,b,c   Gordon, Evian ^d,e   Boutros, Nash N ^f  

^a UTRECHT UNIVERSITY   (Netherlands)

^b RESEARCH INSTITUTE BRAINCLINICS   (Netherlands)

^c NeuroCare Group   (Germany)

^d Brain Resource Ltd   (Australia)

^e Brain Resource International Database   (United States)

^f UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

alpha frequency; antidepressant; EEG; epileptiform; paroxysmal

Indexed keywords

ESCITALOPRAM; SERTRALINE; VENLAFAXINE; ANTIDEPRESSANT AGENT; CITALOPRAM;

ADULT; ALPHA RHYTHM; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EEG ABNORMALITY; EFFECT SIZE; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; EPILEPTIC DISCHARGE; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; REMISSION; RESTING STATE NETWORK; TREATMENT OUTCOME; TREATMENT RESPONSE; DEPRESSION; DRUG EFFECTS; INTERNATIONAL COOPERATION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INTERNATIONALITY; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERTRALINE; TREATMENT OUTCOME; VENLAFAXINE HYDROCHLORIDE;

EID: 85003875062     PISSN: 15500594     EISSN: 21695202     Source Type: Journal    
DOI: 10.1177/1550059415621435     Document Type: Article

References (51)

1. Berger H,. Uber das elektrenkephalogramm des menschen. Arch Psychiatr Nervenkr. 1929; 87: 527-570.
2. Graham MA, Dietlein LF,. Technical details of data acquisition for normative EEG reference library. Analysis of central nervous system and cardiovascular data using computer methods. NASA SP-72. 1965: 433.
3. Boutros NN, Kirollos SB, Pogarell O, Gallinat J,. Predictive value of isolated epileptiform discharges for a favorable therapeutic response to antiepileptic drugs in nonepileptic psychiatric patients. J Clin Neurophysiol. 2014; 31: 21-30. doi: 10.1097/WNP.0000000000000023.
4. Kasteleijn-Nolst Trenité DG, Vermeiren R,. The impact of subclinical epileptiform discharges on complex tasks and cognition: relevance for aircrew and air traffic controllers. Epilepsy Behav. 2005; 6: 31-34. doi: 10.1016/j.yebeh.2004.10.005.
5. Struve FA, Boutros NN,. Somatic implications of generalized and/or focal EEG slowing in psychiatric patients. Clin EEG Neurosci. 2005; 36: 171-175.
6. Boutros NN,. Diffuse electroencephalogram slowing in psychiatric patients: a preliminary report. J Psychiatry Neurosci. 1996; 21: 259-263.
7. Arns M, Gunkelman J, Breteler M, Spronk D,. EEG phenotypes predict treatment outcome to stimulants in children with ADHD. J Integr Neurosci. 2008; 7: 421-438.
8. Arns M, Spronk D, Fitzgerald PB,. Potential differential effects of 9 Hz rTMS and 10 Hz rTMS in the treatment of depression. Brain Stimul. 2010; 3: 124-126. doi: 10.1016/j.brs.2009.07.005.
9. Arns M,. EEG-based personalized medicine in ADHD: individual alpha peak frequency as an endophenotype associated with nonresponse. J Neurother. 2012; 16: 123-141.
10. Ulrich G, Renfordt E, Zeller G, Frick K,. Interrelation between changes in the EEG and psychopathology under pharmacotherapy for endogenous depression. A contribution to the predictor question. Pharmacopsychiatry. 1984; 17: 178-183. doi: 10.1055/s-2007-1017433.
11. Arns M, Olbrich S,. Personalized medicine in ADHD and depression: use of pharmaco-EEG. Curr Top Behav Neurosci. 2014; 21: 345-370. doi: 10.1007/7854-2014-295.
12. Olbrich S, Arns M,. EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response. Int Rev Psychiatry. 2013; 25: 604-618. doi: 10.3109/09540261.2013.816269.
13. Arns M, Bruder G, Hegerl U, et al. EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study. [published online June 27, 2015]. Clin Neurophysiol. doi: 10.1016/j.clinph.2015.05.032.
14. Arns M, Etkin A, Hegerl U, et al. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome? Eur Neuropsychopharmacol. 2015; 25: 1190-1200. doi: 10.1016/j.euroneuro.2015.03.007.
15. Shelley BP, Trimble MR, Boutros NN,. Electroencephalographic cerebral dysrhythmic abnormalities in the trinity of nonepileptic general population, neuropsychiatric, and neurobehavioral disorders. J Neuropsychiatry Clin Neurosci. 2008; 20: 7-22. doi: 10.1176/appi.neuropsych.20.1.7.
16. Arns M,. Personalized Medicine in ADHD and Depression: A Quest for EEG Treatment Predictors [doctoral thesis]. Utrecht, Netherlands: Utrecht; 2011.
17. Arns M, Drinkenburg P, Fitzgerald P, Kenemans L,. Neurophysiological predictors of non-response to rTMS in depression. Brain Stimul. 2012; 5: 569-576. doi: 10.1016/j.brs.2011.12.003.
18. Bragatti JA, Torres CM, Cherubini PA, Leistner-Segal S, Bianchin MM,. Is interictal EEG activity a biomarker for mood disorders in temporal lobe epilepsy? Clin Neurophysiol. 2014; 125: 1952-1958. doi: 10.1016/j.clinph.2014.02.013.
19. Lennox-Buchtal M, Buchtal F, Rosenfalck P,. Correlation of electroencephalographic findings with crash rate of military jet pilots. Epilepsia. 1960; 1: 366-372.
20. Goodwin JE,. The significance of alpha variants in the EEG, and their relationship to an epileptiform syndrome. Am J Psychiatry. 1947; 104: 369-379.
21. Richter PL, Zimmerman EA, Raichle ME, Liske E,. Electroencephalograms of 2,947 United States Air Force Academy cadets (1965-1969). Aerosp Med. 1971; 42: 1011-1014.
22. Høgh P, Smith SJ, Scahill RI, et al. Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatment. Neurology. 2002; 58: 298-301.
23. Mintz M, Legoff D, Scornaienchi J, et al. The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production. J Child Neurol. 2009; 24: 807-815. doi: 10.1177/0883073808330762.
24. Porras-Kattz E, Harmony T, Ricardo-Garcell J, et al. Magnesium valproate in learning disabled children with interictal paroxysmal EEG patterns: preliminary report. Neurosci Lett. 2011; 492: 99-104. doi: 10.1016/j.neulet.2011.01.065.
25. McNamara ME, Fogel BS,. Anticonvulsant-responsive panic attacks with temporal lobe EEG abnormalities. J Neuropsychiatry Clin Neurosci. 1990; 2: 193-196.
26. Adamaszek M, Olbrich S, Gallinat J,. The diagnostic value of clinical EEG in detecting abnormal synchronicity in panic disorder. Clin EEG Neurosci. 2011; 42: 166-174.
27. Itil TM, Rizzo AE,. Behavior and quantitative EEG correlations during treatment of behavior-disturbed adolescents. Electroencephalogr Clin Neurophysiol. 1967; 23: 81.
28. Davids E, Kis B, Specka M, Gastpar M,. A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30: 1033-1038. doi: 10.1016/j.pnpbp.2006.03.035.
29. Silva RR, Munoz DM, Alpert M,. Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis. J Am Acad Child Adolesc Psychiatry. 1996; 35: 352-358.
30. Yasuhara A,. Correlation between EEG abnormalities and symptoms of autism spectrum disorder (ASD). Brain Dev. 2010; 32: 791-798. doi: 10.1016/j.braindev.2010.08.010.
31. Bogdanoff BM, Stafford CR, Green L, Gonzalez CF,. Computerized transaxial tomography in the evaluation of patients with focal epilepsy. Neurology. 1975; 25: 1013-1017.
32. Koutroumanidis M, Martin-Miguel C, Hennessy MJ, et al. Interictal temporal delta activity in temporal lobe epilepsy: correlations with pathology and outcome. Epilepsia. 2004; 45: 1351-1367.
33. Blume WT, Borghesi JL, Lemieux JF,. Interictal indices of temporal seizure origin. Ann Neurol. 1993; 34: 703-709. doi: 10.1002/ana.410340513.
34. Tao JX, Chen X-J, Baldwin M, et al. Interictal regional delta slowing is an EEG marker of epileptic network in temporal lobe epilepsy. Epilepsia. 2011; 52: 467-476. doi: 10.1111/j.1528-1167.2010.02918.x.
35. Williams LM, Rush AJ, Koslow SH, et al. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials. 2011; 12: 4. doi: 10.1186/1745-6215-12-4.
36. Saveanu R, Etkin A, Duchemin A-M, et al. The International Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment. J Psychiatr Res. 2015; 61: 1-12. doi: 10.1016/j.jpsychires.2014.12.018.
37. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59: 22-33.
38. Paul RH, Gunstad J, Cooper N, et al. Cross-cultural assessment of neuropsychological performance and electrical brain function measures: additional validation of an international brain database. Int J Neurosci. 2007; 117: 549-568. doi: 10.1080/00207450600773665.
39. Williams LM, Simms E, Clark CR, Paul RH, Rowe D, Gordon E,. The test-retest reliability of a standardized neurocognitive and neurophysiological test battery: "neuromarker". Int J Neurosci. 2005; 115: 1605-1630. doi: 10.1080/00207450590958475.
40. Gratton G, Coles MG, Donchin E,. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol. 1983; 55: 468-484.
41. Niedermeyer E,. Abnormal EEG patterns: epileptic and paroxysmal. In: Niedermeyer E, Lopes Da Silva F, eds. Electroencephalography: Basic Principles, Clinical Applications, and Related Fields. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005: 255-280.
42. Krauss GL, Fisher RS, Kaplan PW,. The Johns Hopkins Atlas of Digital EEG: An Interactive Training Guide. Baltimore, MD: Johns Hopkins University Press; 2010.
43. Sharbrough FW,. Nonspecific abnormal EEG patterns. In: Niedermeyer E, Lopes Da Silva F, eds. Electroencephalography: Basic Principles, Clinical Applications, and Related Fields. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005: 235-254.
44. Boutros NN,. Standard EEG: A Research Roadmap for Neuropsychiatry. New York, NY: Springer; 2014.
45. Noachtar S, Binnie C, Ebersole J, Mauguière F, Sakamoto A, Westmoreland B,. A glossary of terms most commonly used by clinical electroencephalographers and proposal for the report form for the EEG findings. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl. 1999; 52: 21-41.
46. Sanchez C, Reines EH, Montgomery SA,. A comparative review of escitalopram, paroxetine, and sertraline: are they all alike? Int Clin Psychopharmacol. 2014; 29: 185-196. doi: 10.1097/YIC.0000000000000023.
47. Rossi S, Hallett M, Rossini PM, Pascual-Leone A, The Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009; 120: 2008-2039. doi: 10.1016/j.clinph.2009.08.016.
48. Blumer D,. Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders. Harv Rev Psychiatry. 2000; 8: 8-17.
49. Blumer D, Montouris G, Davies K,. The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. Epilepsy Behav. 2004; 5: 826-840. doi: 10.1016/j.yebeh.2004.08.003.
50. Nuwer MR, Comi G, Emerson R, et al. IFCN standards for digital recording of clinical EEG. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl. 1999; 52: 11-14.
51. Derry CP, Duncan S,. Sleep and epilepsy. Epilepsy Behav. 2013; 26: 394-404. doi: 10.1016/j.yebeh.2012.10.033.